{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:04:13Z","timestamp":1780329853649,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.msard.2026.107174","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:29:50Z","timestamp":1774970990000},"page":"107174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnosis and antibody status awareness in neuromyelitis optica spectrum disorder and MOG-associated disease: A cross-sectional study"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-1199","authenticated-orcid":false,"given":"Samira Luisa","family":"Ap\u00f3stolos-Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Terrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Santana de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Simon Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Macedo de Souza Tieppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Aguiar Santos Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Baleeiro Rodrigues Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Vieira Marques Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Santillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rosalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Holanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarso","family":"Adoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagoberto","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.msard.2026.107174_bib0031","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1177\/13524585241267231","article-title":"Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorder","volume":"30","author":"Abbatemarco","year":"2024","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2026.107174_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.17712\/nsj.2019.4.20190031","article-title":"Multiple sclerosis patients knowledge in Saudi Arabia","volume":"24","author":"Abulaban","year":"2019","journal-title":"Neurosciences"},{"issue":"12","key":"10.1016\/j.msard.2026.107174_bib0030","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107174_bib0013","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamaneurol.2023.2523","article-title":"Immunoglobulin A antibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with central nervous system demyelination","volume":"80","author":"Ayroza Galv\u00e3o Ribeiro Gomes","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2026.107174_bib0019","article-title":"Multiple sclerosis awareness in Jordan, and how does it affect the time of diagnosis","author":"Bahou","year":"2023","journal-title":"J. Hosp. Healthc. Adm."},{"issue":"3","key":"10.1016\/j.msard.2026.107174_bib0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"7_Supplement_1","key":"10.1016\/j.msard.2026.107174_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0001051032.57644.0a","article-title":"Socioeconomic factors associated with \u22652-year delayed diagnosis of neuromyelitis optica spectrum disorder (NMOSD) in the United States","volume":"103","author":"Blackowicz","year":"2024","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2026.107174_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1842","article-title":"Cognitive impairment in NMOSD-more questions than answers","volume":"10","author":"Czarnecka","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2026.107174_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.966428","article-title":"The patient journey with NMOSD: from initial diagnosis to chronic condition","volume":"13","author":"Delgado-Garcia","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107174_bib0001","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.26858","article-title":"Time to disability milestones and annualized relapse rates in NMOSD and MOGAD","volume":"95","author":"Duchow","year":"2024","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107174_bib0006","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.msard.2026.107174_bib0037","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0738-3991(02)00239-2","article-title":"Health literacy and knowledge of chronic disease","volume":"51","author":"Gazmararian","year":"2003","journal-title":"Patient Educ. Couns."},{"issue":"8","key":"10.1016\/j.msard.2026.107174_bib0026","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.3390\/ijms23084154","article-title":"Adverse events in NMOSD therapy","volume":"23","author":"Giglhuber","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107174_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1352458509352865","article-title":"The multiple sclerosis knowledge questionnaire: a self-administered instrument for recently diagnosed patients","volume":"16","author":"Giordano","year":"2010","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2026.107174_bib0034","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40263-025-01205-4","article-title":"Multiple sclerosis in people of diverse racial and ethnic backgrounds: presentation, disease course, and interactions with disease-modifying therapy","volume":"39","author":"Li","year":"2025","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.msard.2026.107174_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064609","article-title":"Exploring health literacy in patients with chronic diseases in Chongqing, China: a cross-sectional study","volume":"13","author":"Liu","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.msard.2026.107174_bib0032","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s13524-016-0484-8","article-title":"Racial inequality in education in Brazil: a twins fixed-effects approach","volume":"53","author":"Marteleto","year":"2016","journal-title":"Demography"},{"issue":"11","key":"10.1016\/j.msard.2026.107174_bib0023","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1055\/s-0043-1777002","article-title":"Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience","volume":"81","author":"Messias","year":"2023","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.msard.2026.107174_bib0016","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s40120-022-00431-y","article-title":"Understanding treatment decisions in neuromyelitis optica spectrum disorder: a global clinical record review with patient interviews","volume":"12","author":"Min","year":"2023","journal-title":"Neurol. Ther."},{"issue":"17","key":"10.1016\/j.msard.2026.107174_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178538","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: pathophysiology, clinical patterns, and therapeutic challenges of intractable and severe forms","volume":"26","author":"Misu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107174_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106222","article-title":"MOG-IgG is rare in AQP4-IgG seronegative NMO phenotype in Brazil","volume":"93","author":"Pedrosa","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2026.107174_bib0010","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107174_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12883-025-04172-x","article-title":"Multiple sclerosis patients\u2019 journey delay in diagnosis and treatment: a multicenter study","volume":"25","author":"Ragab","year":"2025","journal-title":"BMC Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107174_bib0024","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/01616412.2021.1949686","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorder testing and treatment availability in Latin America","volume":"43","author":"Rojas","year":"2021","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.msard.2026.107174_bib0014","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107174_bib0039","first-page":"e234","article-title":"Social determinants, health literacy, and disparities: intersections and controversies","volume":"5","author":"Schillinger","year":"2021","journal-title":"Health Lit. Res. Pract."},{"issue":"10","key":"10.1016\/j.msard.2026.107174_bib0007","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.pec.2015.06.022","article-title":"Shared decision making: concepts, evidence, and practice","volume":"98","author":"Stiggelbout","year":"2015","journal-title":"Patient Educ. Couns."},{"issue":"2","key":"10.1016\/j.msard.2026.107174_bib0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107174_bib0011","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107174_bib0027","unstructured":"\u201cShared decision-making in autoimmune neurology: making decisions in the face of uncertainty - PubMed\u201d. Acesso em: 7 de mar\u00e7o de. 2026. [Online]. Dispon\u00edvel em: https:\/\/pubmed.ncbi.nlm.nih.gov\/33842067\/."},{"issue":"10","key":"10.1016\/j.msard.2026.107174_bib0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107174_bib0033","first-page":"1","article-title":"A roadmap to increasing access to AQP4-ig testing for NMOSD: expert recommendations","volume":"83","author":"Vass\u00e3o-Araujo","year":"2025","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.msard.2026.107174_bib0021","first-page":"206","article-title":"Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients","volume":"16","author":"Vlahiotis","year":"2010","journal-title":"J. Manag. Care Pharm. JMCP"},{"issue":"7","key":"10.1016\/j.msard.2026.107174_bib0004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107174_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.msard.2026.107174_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/10810730.2010.499981","article-title":"Health literacy and communication quality in health care organizations","volume":"15","author":"Wynia","year":"2010","journal-title":"J. Health Commun."},{"key":"10.1016\/j.msard.2026.107174_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106255","article-title":"The awareness and knowledge of multiple sclerosis patients about their disease: a Lebanese cross-sectional study","volume":"95","author":"Zeineddine","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.msard.2026.107174_bib0003","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp-2022-330901","article-title":"Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study","volume":"94","author":"ZhangBao","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:25:38Z","timestamp":1780327538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826002105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2211034826002105"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107174","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and antibody status awareness in neuromyelitis optica spectrum disorder and MOG-associated disease: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107174"}}